safingol has been researched along with Breast Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Alan, EP; Angel, GL; Augusto, RC; Cecilia, RM; Darling, D; Elena, MJ; Ivonne, OC; Jonathan, FM; José, CB; Lubriel, MH; Sayuri, VJ | 1 |
Ahn, EH; Chang, CC; Schroeder, JJ | 1 |
Fine, RL; Harrison, SD; Sachs, CW; Safa, AR | 1 |
3 other study(ies) available for safingol and Breast Neoplasms
Article | Year |
---|---|
UHPLC-MS/MS Studies and Antiproliferative Effects in Breast Cancer Cells of Mexican Sargassum.
Topics: Animals; Antineoplastic Agents; Breast Neoplasms; Cell Line, Tumor; Chromatography, High Pressure Liquid; Ethanol; Female; Humans; Mexico; Mice; NIH 3T3 Cells; Plant Extracts; Sargassum; Tandem Mass Spectrometry | 2023 |
Evaluation of sphinganine and sphingosine as human breast cancer chemotherapeutic and chemopreventive agents.
Topics: Apoptosis; Breast Neoplasms; Cell Cycle; Cell Transformation, Neoplastic; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Humans; Inhibitory Concentration 50; Neoplastic Stem Cells; Sphingosine; Tumor Cells, Cultured | 2006 |
Partial inhibition of multidrug resistance by safingol is independent of modulation of P-glycoprotein substrate activities and correlated with inhibition of protein kinase C.
Topics: Affinity Labels; Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Brain; Breast Neoplasms; Cell Line; Cell Membrane; Cell Survival; Daunorubicin; Doxorubicin; Drug Resistance, Multiple; Enzyme Inhibitors; Female; Humans; Intracellular Signaling Peptides and Proteins; Membrane Proteins; Myristoylated Alanine-Rich C Kinase Substrate; Phorbol 12,13-Dibutyrate; Protein Kinase C; Proteins; Rats; Recombinant Proteins; Sphingosine; Substrate Specificity; Tumor Cells, Cultured; Verapamil; Vinblastine | 1995 |